Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP35 activates cell. 2 / 2

| 2

➶

eidos

"Further functional studies showed that enhanced USP35 expression promoted CRC cell proliferation and resistance to oxaliplatin ( OXA ) and 5-fluorouracil ( 5-FU ) , whereas USP35 depletion impeded cell proliferation and sensitized cells to OXA and 5-FU treatments ."

36864055

➶

eidos

"USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer ."

36864055

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...